These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2050925)

  • 1. Effect of superoxide dismutase on infarct size and postischemic recovery of myocardial contractility and metabolism in dogs.
    Vanhaecke J; Van de Werf F; Ronaszeki A; Flameng W; Lesaffre E; De Geest H
    J Am Coll Cardiol; 1991 Jul; 18(1):224-30. PubMed ID: 2050925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Reperfusion injury" by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow.
    Przyklenk K; Kloner RA
    Circ Res; 1989 Jan; 64(1):86-96. PubMed ID: 2909304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant tissue-type plasminogen activator ameliorates ischemic derangements induced by thrombotic occlusion in closed chest anesthetized dogs.
    Egashira K; Kawai K; Nagano M; Sakuma A; Nakamura M; Tomoike H
    J Am Coll Cardiol; 1992 Jul; 20(1):218-25. PubMed ID: 1607528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs.
    Nejima J; Knight DR; Fallon JT; Uemura N; Manders WT; Canfield DR; Cohen MV; Vatner SF
    Circulation; 1989 Jan; 79(1):143-53. PubMed ID: 2910539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: a demonstration of myocardial salvage.
    Chi LG; Tamura Y; Hoff PT; Macha M; Gallagher KP; Schork MA; Lucchesi BR
    Circ Res; 1989 Apr; 64(4):665-75. PubMed ID: 2702730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs.
    Uraizee A; Reimer KA; Murry CE; Jennings RB
    Circulation; 1987 Jun; 75(6):1237-48. PubMed ID: 3568330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of calcium channel antagonist treatment and oxygen radical scavenging on infarct size and the no-reflow phenomenon in reperfused hearts.
    Villari B; Ambrosio G; Golino P; Ragni M; Focaccio A; Tritto I; Salvatore M; Chiariello M
    Am Heart J; 1993 Jan; 125(1):11-23. PubMed ID: 8417506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart.
    Tamura Y; Chi LG; Driscoll EM; Hoff PT; Freeman BA; Gallagher KP; Lucchesi BR
    Circ Res; 1988 Nov; 63(5):944-59. PubMed ID: 3180357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of human recombinant superoxide dismutase on canine myocardial infarction.
    Patel BS; Jeroudi MO; O'Neill PG; Roberts R; Bolli R
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H369-80. PubMed ID: 2309904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced myocardial salvage by combined treatment with recombinant single-chain urokinase-type plasminogen activator and recombinant human superoxide dismutase in a canine coronary thrombosis model.
    Fincke U; Schneider J; Friderichs E; Giertz H; Flohé L
    Arzneimittelforschung; 1988 Jan; 38(1):138-42. PubMed ID: 3365272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxide dismutase plus catalase therapy delays neither cell death nor the loss of the TTC reaction in experimental myocardial infarction in dogs.
    Tanaka M; Richard VJ; Murry CE; Jennings RB; Reimer KA
    J Mol Cell Cardiol; 1993 Apr; 25(4):367-78. PubMed ID: 8340930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Limitation of myocardial infarct size by polyethylene glycol-conjugated superoxide dismutase in a canine model of 90 min coronary occlusion followed by 4 days of reperfusion].
    Tamura Y; Saito S; Hatano M; Lucchesi BR
    Kokyu To Junkan; 1989 Feb; 37(2):201-8. PubMed ID: 2727408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of superoxide dismutase administered by coronary sinus retroperfusion on ischemic reperfused canine heart].
    Uriuda Y; Hatori N; Okuda E; Yoshizu H; Tanaka S
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Jan; 41(1):7-15. PubMed ID: 8459148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superoxide dismutase plus catalase improve contractile function in the canine model of the "stunned myocardium".
    Przyklenk K; Kloner RA
    Circ Res; 1986 Jan; 58(1):148-56. PubMed ID: 3943152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet GPIIb/IIIa receptor blockade reduces infarct size in a canine model of ischemia-reperfusion.
    Kingma JG; Plante S; Bogaty P
    J Am Coll Cardiol; 2000 Dec; 36(7):2317-24. PubMed ID: 11127479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of coronary venous retroinfusion of superoxide dismutase and catalase on reperfusion arrhythmias, myocardial function, and infarct size in dogs.
    Hatori N; Miyazaki A; Tadokoro H; Rydén L; Moll J; Rajagopalan RE; Fishbein MC; Meerbaum S; Corday E; Drury JK
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):396-404. PubMed ID: 2476618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury.
    Ambrosio G; Becker LC; Hutchins GM; Weisman HF; Weisfeldt ML
    Circulation; 1986 Dec; 74(6):1424-33. PubMed ID: 3779923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled reperfusion after myocardial ischemia in a canine model monitored by two-dimensional phosphorus 31 chemical shift spectroscopic imaging.
    Campbell CM; Wisenberg G; Sykes J; Thompson RT
    Am Heart J; 1997 May; 133(5):508-16. PubMed ID: 9141372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels.
    Kersten JR; Schmeling TJ; Hettrick DA; Pagel PS; Gross GJ; Warltier DC
    Anesthesiology; 1996 Oct; 85(4):794-807; discussion 27A. PubMed ID: 8873550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.